首页> 外国专利> Diastereomeric 4,4-di:substd.-2-imidazolin-5-one derivs. - prepd. by asymmetric induction, intermediates for optically pure aminoacid(s) such as methyl-DOPA

Diastereomeric 4,4-di:substd.-2-imidazolin-5-one derivs. - prepd. by asymmetric induction, intermediates for optically pure aminoacid(s) such as methyl-DOPA

机译:非对映体4,4-二:取代-2-咪唑啉-5-酮-准备通过不对称诱导,可以制备光学纯氨基酸的中间体,例如甲基-DOPA

摘要

Imidazoline-5-one derivs. of formula (I) are new: R1 is the optical active residue of a primary amine or aminoacid. R2 is H, 1-4C alkyl, benzyl or phenyl. R3 is 1-4C alkyl (opt. substd. by alkoxy, alkylthio or dialkyamino (all 1-4C alkyl), benzyloxy, benzylthio, 1-4C acyloxy, CN, 2-5C carbalkoxy, benzoyl or phenyl (the rings opt. substd. by 103 halo, NO2, 1-4C alkyl, alkoxy, or alkylthio, benzyloxy, 1-4C acyloxy or acylamino, or by one phenoxy (itself opt. substd by 1-4C alkoxy or acyloxy), CF3 or methylenedioxy), or R3 is allyl or phenyl. R4 is 1-6C alkyl opt. substd. by alkoxy, alkylthio or dialkylamino (all 1-4C alkyl), piperidino, pyrrolidino, benzyloxy, benzylthio, CN, 2-5C carbalkoxy, benzoyl or phenyl (both opt. substd. as for corresp. gps. R3), or R4 is ClCH2 or allyl. Q is pyridyl, furyl, thienyl, naphthyl, benzothienyl or bromobenzofuran. Where R3 and R4 are different, (I) are intermediates (by conventional hydrolysis) for optically active alpha-e ethyl-arylalanines, e.g. alpha-methyl-dopa (an antihypertensive) and alpha-methyltyrosine (a tranquilliser). (I) are prepd. by alkylation of corresp. cpds. (I) where R4 is H alkylation at the 4-posn. proceeds with nearly 100% asymmetric induction (the nature of R1 determines the configuration at this position) and practically no O-alkylation occurs. In an example, 1-L-alpha-phenylethyl-4-methyl-4-benzyl-2-imidazoline-5-one was prepd. from the L-alpha-phenylethylamide of alpha-isocyanopropionic acid/n-BuLi and benzyl bromide.
机译:咪唑啉-5-酮衍生物。式(I)的R 5是新的:R 1是伯胺或氨基酸的光学活性残基。 R 2是H,1-4C烷基,苄基或苯基。 R3为1-4C烷基(被烷氧基,烷硫基或二烷基氨基取代(所有1-4C烷基),苄氧基,苄硫基,1-4C酰氧基,CN,2-5C碳烷氧基,苯甲酰基或苯基(被取代的环)通过103卤素,NO2、1-4C烷基,烷氧基或烷硫基,苄氧基,1-4C酰氧基或酰基氨基,或一种苯氧基(其本身优选由1-4C烷氧基或酰氧基取代),CF3或亚甲基二氧基),或R 3是烯丙基或苯基.R 4是1-6C烷基,优选被烷氧基,烷硫基或二烷氨基(所有1-4C烷基),哌啶子基,吡咯烷基,苄氧基,苄硫基,CN,2-5C碳烷氧基,苯甲酰基或苯基取代分别对应于gps.R3)或R4为ClCH2或烯丙基.Q为吡啶基,呋喃基,噻吩基,萘基,苯并噻吩基或溴苯并呋喃。其中R3和R4不同,(I)为中间体(通过常规水解) )用于旋光的α-e乙基-芳基丙氨酸,例如α-甲基-多巴(降压药)和α-甲基酪氨酸(镇定剂)(I)通过相应的cpds烷基化制备(I),其中R4为H烷基化n在4位位置。继续进行几乎100%的不对称感应(R1的性质决定了该位置的构型),并且几乎没有O-烷基化发生。在一个实例中,制备1-L-α-苯乙基-4-甲基-4-苄基-2-咪唑啉-5-酮。由α-异氰基丙酸/ n-BuLi的L-α-苯基乙酰胺和苄基溴组成。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号